Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Riociguat in Hepatic Impairment
NCT04366622Phase 1Completed
- Sponsor
- Bayer
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of riociguat in pulmonary hypertension (PH) (4 arms), sponsored by Bayer. Primary endpoints: Area Under the Curve, Maximum Plasma Concentration and 4 more. Started Apr 2010; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04366622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366622.